In Utero Losartan Withdrawal and Subsequent Development of Fetal Inferior Vena Cava Thrombosis

Jamie N. Bakkum, Brian Brost, Keith L. Johansen, Bruce W. Johnston, William J. Watson

Obstetrics and Gynecology · 2006 · 10 citations · 6 references

Concepts

Abstract

In Brief BACKGROUND: Angiotensin receptor blockers are antihypertensive medications prescribed by a wide variety of physicians, especially for patients with coexistent diabetes mellitus. Angiotensin receptor blockers, as well as angiotensin-converting enzyme inhibitors, are contraindicated in pregnancy. CASE: We describe the reversal of losartan-induced oligohydramnios at 27 weeks of gestation with subsequent development of fetal thrombosis and possible mechanism of action for this extremely rare in utero complication. CONCLUSION: This theory may help explain the fetal stillbirths in women taking this class of medications during the second and third trimester of pregnancy. Development of a fetal inferior vena cava thrombosis appears temporally related to abrupt cessation of angiotensin receptor blocker use during pregnancy.

References

6